Second generation interferon-gamma release assays (IGRAs) might be used to segregate active TB cases especially in low incidence areas.[16] Serology in our study had the least specificity for diagnosis (area under curve in ROC 0.502) and drug resistance (area under curve in ROC 0.497) which is very low. This evidence concerns the gene IFNG and tuberculosis.